免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Biobeat 平台,BB-613WP 贴片

K 號:K212153 · 2022-03-25

決定日期2022-03-25
產品代碼DQA
諮詢委員會履歷
決定相當於

器材摘要

Biobeat Platform, BB-613WP Patch is the device name listed in this FDA 510(k) record. The listed applicant is Biobeat Technologies , Ltd.. It received FDA 510(k) clearance on 2022-03-25 under 510(k) number K212153. The device is classified under product code DQA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Biobeat Platform, BB-613WP Patch?

Biobeat Platform, BB-613WP Patch is a medical device that received FDA 510(k) clearance on 2022-03-25. The listed applicant is Biobeat Technologies , Ltd.. The 510(k) number is K212153.

When did Biobeat Platform, BB-613WP Patch receive FDA 510(k) clearance?

Biobeat Platform, BB-613WP Patch received FDA 510(k) clearance on 2022-03-25, under 510(k) number K212153.

Who is the listed applicant for Biobeat Platform, BB-613WP Patch?

The FDA 510(k) record lists Biobeat Technologies , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Biobeat Platform, BB-613WP Patch?

The FDA product code for Biobeat Platform, BB-613WP Patch is DQA.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Biobeat Technologies , Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DQA)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑